Riad El Kebbaj

Prof. Riad El Kebbaj

Higher Institute of Health Sciences, Hassan First University of settat,Morocco, Settat, Casablanca-Settat, Morocco
orcid
Head of the Laboratory "Sciences and Engineering of Biomedic...

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2025 in Molecules
Verified
Journal Article
Open access
PDF file
BEBasma ES-SAI
Basma ES-SAI
HWHicham Wahnou
Hicham Wahnou
SBSalma Benayad
Salma Benayad
SRSoufiane RABBAA
Soufiane RABBAA
YLYassir Laaziouez
Yassir Laaziouez
Raphaël DuvalRaphaël Duval
Raphaël Duval
Gamma-tocopherol (γ-tocopherol), a major isoform of vitamin E, exhibits potent antioxidant, anti-inflammatory, and anticancer properties, making it a promising therapeutic candidate for treating oxidative stress-related diseases. Unlike other tocopherol isoforms, γ-tocopherol effectively neutralizes reactive oxygen species (ROS) and reactive nitrogen species (RNS), providing robust cellular protection against oxidative damage and lipid peroxidation. Its anti-inflammatory effects are mediated through the modulation of pathways involving cyclooxygenase-2 (COX-2) and tumor necrosis factor-alpha (TNF-α), reducing chronic inflammation and its associated risks. In cancer therapy, γ-tocopherol demonstrates multifaceted activity, including the inhibition of tumor growth, induction of apoptosis, and suppression of angiogenesis, with significant efficacy observed in cancers such as prostate, lung, and colon. Preclinical and clinical studies support its efficacy in mitigating oxidative stress, inflammation, and cancer progression, with excellent tolerance at physiological levels. However, high doses necessitate careful evaluation to minimize adverse effects. This review consolidates current knowledge on γ-tocopherol’s biological activities and clinical implications, underscoring its importance as a natural compound for managing inflammation, oxidative stress, and cancer. As a perspective, advancements in nanoformulation technology could enhance γ-tocopherol’s bioavailability, stability, and targeted delivery, offering the potential to optimize its therapeutic application in the future.

1 April 2014 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YKYoussef El Kharrassi
Youssef El Kharrassi
MSMohammad Samadi
Mohammad Samadi
TLTatiana Lopez
Tatiana Lopez
TNThomas Nury
Thomas Nury
Riad El KebbajRiad El Kebbaj
Riad El Kebbaj
MCMustapha Cherkaoui-Malki
Mustapha Cherkaoui-Malki

15 January 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
HWHicham Wahnou
Hicham Wahnou
Riad El KebbajRiad El Kebbaj
Riad El Kebbaj
BLBertrand Liagre
Bertrand Liagre
VSVincent Sol
Vincent Sol
Youness LimamiYouness Limami
Youness Limami
Raphaël DuvalRaphaël Duval
Raphaël Duval
Curcumin, a bioactive compound derived from the rhizome of Curcuma longa L., has garnered significant attention for its potent anticancer properties. Despite its promising therapeutic potential, its poor bioavailability, rapid metabolism, and low water solubility hinder curcumin’s clinical application. Nanotechnology offers a viable solution to these challenges by enabling the development of curcumin-based nanoparticles (CNPs) that enhance its bioavailability and therapeutic efficacy. This review provides a comprehensive overview of the recent advancements in the design and synthesis of CNPs for cancer therapy. We discuss various NP formulations, including polymeric, lipid-based, and inorganic nanoparticles, highlighting their role in improving curcumin’s pharmacokinetic and pharmacodynamic profiles. The mechanisms by which CNPs exert anticancer effects, such as inducing apoptosis, inhibiting cell proliferation, and modulating signaling pathways, are explored in details. Furthermore, we examine the preclinical and clinical studies that have demonstrated the efficacy of CNPs in treating different types of tumors, including breast, colorectal, and pancreatic cancers. Finally, the review addresses the current challenges and future perspectives in the clinical translation of CNPs, emphasizing the need for further research to optimize their design for targeted delivery and to enhance their therapeutic outcomes. By synthesizing the latest research, this review underscores the potential of CNPs as a promising avenue for advancing cancer therapy.

20 November 2023 in Cancers
Verified
Journal Article
Open access
PDF file
SBSalma Benayad
Salma Benayad
HWHicham Wahnou
Hicham Wahnou
Riad El KebbajRiad El Kebbaj
Riad El Kebbaj
BLBertrand Liagre
Bertrand Liagre
VSVincent Sol
Vincent Sol
Youness LimamiYouness Limami
Youness Limami
Cancer, characterized by the unregulated growth and dissemination of malignantly transformed cells, presents a significant global health challenge. The multistage process of cancer development involves intricate biochemical and genetic alterations within target cells. Cancer chemoprevention has emerged as a vital strategy to address this complex issue to mitigate cancer’s impact on healthcare systems. This approach leverages pharmacologically active agents to block, suppress, prevent, or reverse invasive cancer development. Among these agents, piperine, an active alkaloid with a wide range of therapeutic properties, including antioxidant, anti-inflammatory, and immunomodulatory effects, has garnered attention for its potential in cancer prevention and treatment. This comprehensive review explores piperine’s multifaceted role in inhibiting the molecular events and signaling pathways associated with various stages of cancer development, shedding light on its promising prospects as a versatile tool in cancer chemoprevention. Furthermore, the review will also delve into how piperine enhances the effectiveness of conventional treatments such as UV-phototherapy and TRAIL-based therapy, potentially synergizing with existing therapeutic modalities to provide more robust cancer management strategies. Finally, a crucial perspective of the long-term safety and potential side effects of piperine-based therapies and the need for clinical trials is also discussed.
1

Verified
Journal Article
Open access
PDF file
SKSoufiane EL KAMOUNI
Soufiane EL KAMOUNI
Riad El KebbajRiad El Kebbaj
Riad El Kebbaj
Pierre AndreolettiPierre Andreoletti
Pierre Andreoletti
AKAbderrahim El Ktaibi
Abderrahim El Ktaibi
IRIssam Rharrassi
Issam Rharrassi
MCMustapha Cherkaoui-Malki
Mustapha Cherkaoui-Malki
Sepsis causes severe dysregulation of organ functions, via the development of oxidative stress and inflammation. These pathophysiological mechanisms are mimicked in mice injected with bacterial lipopolysaccharide (LPS). Here, protective properties of argan oil against LPS-induced oxidative stress and inflammation are explored in the murine model. Mice received standard chow, supplemented with argan oil (AO) or olive oil (OO) for 25 days, before septic shock was provoked with a single intraperitoneal injection of LPS, 16 hours prior to animal sacrifice. In addition to a rise in oxidative stress and inflammatory markers, injected LPS also caused hepatotoxicity, accompanied by hyperglycemia, hypercholesterolemia and hyperuremia. These LPS-associated toxic effects were blunted by AO pretreatment, as corroborated by normal plasma parameters and cell stress markers (glutathione: GSH) and antioxidant enzymology (catalase, CAT; superoxide dismutase, SOD and glutathione peroxidase, GPx). Hematoxylin–eosin staining revealed that AO can protect against acute liver injury, maintaining a normal status, which is pointed out by absent or reduced LPS-induced hepatic damage markers (i.e., alanine aminotransferase (ALT) and aspartate transaminase (AST)). Our work also indicated that AO displayed anti-inflammatory activity, due to down-regulations of genes encoding pro-inflammatory cytokines Interleukin-6 (IL-6) and Tumor Necrosis Factor-α (TNF-α) and in up-regulations of the expression of anti-inflammatory genes encoding Interleukin-4 (IL-4) and Interleukin-10 (IL-10). OO provided animals with similar, though less extensive, protective changes. Collectively our work adds compelling evidence to the protective mechanisms of AO against LPS-induced liver injury and hence therapeutic potentialities, in regard to the management of human sepsis. Activations of IL-4/Peroxisome Proliferator-Activated Receptors (IL-4/PPARs) signaling and, under LPS, an anti-inflammatory IL-10/Liver X Receptor (IL-10/LXR) route, obviously indicated the high potency and plasticity of the anti-inflammatory properties of argan oil.

29 November 2017 in Journal of Food Measurement and Characterization
Verified
Journal Article
Closed access
PDF file
YKYoussef El Kharrassi
Youssef El Kharrassi
NMNadia Maata
Nadia Maata
MMMouaad Amine Mazri
Mouaad Amine Mazri
SKSoufiane El Kamouni
Soufiane El Kamouni
MTMeryem Talbi
Meryem Talbi
BNBoubker NASSER
Boubker NASSER